(c) 2021 PillSync.com

methylphenidate hydrochloride tablet

INDICATIONS Attention Deficit Disorders, Narcolepsy Attention Deficit Disorders (previously known as Minimal Brain Dysfunction in Children). Other terms being used to describe the behavioral syndrome below include: Hyperkinetic Child Syndrome, Minimal Brain Damage, Minimal Cerebral Dysfunction, Minor Cerebral Dysfunction. Methylphenidate hydrochloride is indicated as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. The diagnosis of this syndrome should not be made with finality when these symptoms are only of comparatively recent origin. Nonlocalizing (soft) neurological signs, learning disability, and abnormal EEG may or may not be present, and a diagnosis of central nervous system dysfunction may or may not be warranted. Special Diagnostic Considerations Specific etiology of this syndrome is unknown, and there is no single diagnostic test. Adequate diagnosis requires the use not only of medical but of special psychological, educational, and social resources. Characteristics commonly reported include: chronic history of short attention span, distractibility, emotional lability, impulsivity, and moderate-to-severe hyperactivity; minor neurological signs and abnormal EEG. Learning may or may not be impaired. The diagnosis must be based upon a complete history and evaluation of the child and not solely on the presence of 1 or more of these characteristics. Drug treatment is not indicated for all children with this syndrome. Stimulants are not intended for use in the child who exhibits symptoms secondary to environmental factors and/or primary psychiatric disorders, including psychosis. Appropriate educational placement is essential and psychosocial intervention is generally necessary. When remedial measures alone are insufficient, the decision to prescribe stimulant medication will depend upon the physician’s assessment of the chronicity and severity of the child’s symptoms.

kvk-tech, inc.


High Cholesterol puts you at risk for Heart Disease and Stroke, two leading causes of death in the US. There are ways to control your cholesterol levels, learn more

3 years ago ROUND YELLOW K 102 methylphenidate hydrochloride tablet

ROUND YELLOW K 102

3 years ago ROUND YELLOW K 102 methylphenidate hydrochloride tablet

K 102 ROUND YELLOW

HOW SUPPLIED

METHYLPHENIDATE HYDROCHLORIDE Tablets USP are available as follows: Tablets 5 mg - yellow, round, flat faced beveled edge tablets, debossed K” above “100” on one side and plain on other side. Bottles of 100 NDC 10702-100-01 Tablets 10 mg - Pale green colored, round, biconvex tablets debossed “K” above bisect “101” on one side and plain on the other side. Bottles of 100 NDC 10702-101-01 Tablets 20 mg - Light yellow, round, biconvex tablets debossed “K” above bisect “102” on one side and plain on the other side. Bottles of 100 NDC 10702-102-01 Store at 25°C (77°F); excursions permitted to 15°C-30°C (59°F-86°F) [see USP Controlled Room Temperature]. Protect from light. Dispense in a tight, light-resistant container, as defined in the USP, with a child-resistant closure. Manufactured by: KVK-Tech, Inc 110 Terry Drive Newtown PA 18940 Item ID #:006209/04 Rev: 10/2019

More pills like ROUND K 102

Related Pills

High Cholesterol puts you at risk for Heart Disease and Stroke, two leading causes of death in the US. There are ways to control your cholesterol levels.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site